{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:23:26Z","timestamp":1758403406983},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T00:00:00Z","timestamp":1412812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ijid.2014.08.012","type":"journal-article","created":{"date-parts":[[2014,10,12]],"date-time":"2014-10-12T10:04:42Z","timestamp":1413108282000},"page":"12-17","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan"],"prefix":"10.1016","volume":"29","author":[{"given":"Yu-Tzu","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Jui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sui-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Song","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ching","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Zhen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2012","series-title":"European guidelines for treatment of HIV-infected adults in Europe","key":"10.1016\/j.ijid.2014.08.012_bib0005"},{"key":"10.1016\/j.ijid.2014.08.012_bib0010","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1468-1293.2011.00917.x","article-title":"Lipid profiles for nevirapine vs. atazanavir\/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naive HIV-1-infected patients (the ARTEN study)","volume":"12","author":"Podzamczer","year":"2011","journal-title":"HIV Med"},{"key":"10.1016\/j.ijid.2014.08.012_bib0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/archdischild-2012-302633","article-title":"Metabolic abnormalities and body composition of HIV-infected children on lopinavir or nevirapine-based antiretroviral therapy","volume":"98","author":"Arpadi","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ijid.2014.08.012_bib0020","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1371\/journal.pmed.0010019","article-title":"Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1","volume":"1","author":"van Leth","year":"2004","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2014.08.012_bib0130","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, 2014. Available at http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/AdultandAdolescentGL.pdf (accessed October 18, 2014)."},{"key":"10.1016\/j.ijid.2014.08.012_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-200501280-00011","article-title":"Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs","volume":"19","author":"Ananworanich","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2014.08.012_bib0035","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/00002030-200108170-00018","article-title":"Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy","volume":"15","author":"Antinori","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2014.08.012_bib0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1468-1293.2007.00477.x","article-title":"Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women","volume":"8","author":"Phanuphak","year":"2007","journal-title":"HIV Med"},{"key":"10.1016\/j.ijid.2014.08.012_bib0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00228-003-0613-3","article-title":"Incidence and risk factors for nevirapine-associated rash","volume":"59","author":"de Maat","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ijid.2014.08.012_bib0050","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0149-2918(98)80105-7","article-title":"Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection","volume":"20","author":"Pollard","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijid.2014.08.012_bib0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1872-034X.2009.00608.x","article-title":"Antiretroviral therapy hepatotoxicity: prevalence, risk factors, and clinical characteristics in a cohort of Han Chinese","volume":"40","author":"Gao","year":"2010","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ijid.2014.08.012_bib0060","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/1545109709343967","article-title":"Adverse drug reactions to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimen: a 24-week prospective study","volume":"8","author":"Jena","year":"2009","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"10.1016\/j.ijid.2014.08.012_bib0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/FPC.0b013e32831d0faf","article-title":"HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients","volume":"19","author":"Chantarangsu","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.ijid.2014.08.012_bib0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-6405-6-22","article-title":"HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients","volume":"6","author":"Likanonsakul","year":"2009","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.ijid.2014.08.012_bib0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2217\/14622416.9.2.207","article-title":"Pharmacogenetic information derived from analysis of HLA alleles","volume":"9","author":"Gatanaga","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ijid.2014.08.012_bib0080","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ajg.2008.159","article-title":"Seroprevalence of chronic hepatitis B virus infection among Taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination","volume":"104","author":"Sun","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ijid.2014.08.012_bib0085","unstructured":"Center for Disease Control. Guidelines for diagnosis and treatment of HIV\/AIDS. Taiwan: CDC; 2010. Available at: http:\/\/www.cdc.gov.tw\/infectionreportinfo.aspx?treeid=075874dc882a5bfd&nowtreeid=8dba723ff186fac0&tid=3B00A7FD7543115A (accessed August 4, 2014)."},{"key":"10.1016\/j.ijid.2014.08.012_bib0090","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/jac\/dkr601","article-title":"Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan","volume":"67","author":"Lai","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2014.08.012_bib0095","unstructured":"National Institutes of Health. Division of AIDS table for grading the severity of adult and pediatric adverse events, 2004 (Clarification August 2009)., 2009. Available at: http:\/\/rsc.tech-res.com\/document\/safetyandpharmacovigilance\/table_for_grading_severity_of_adult_pediatric_adverse_events.pdf (accessed April 8, 2013)."},{"key":"10.1016\/j.ijid.2014.08.012_bib0100","unstructured":"Boehringer Ingelheim Pharmaceuticals, Inc. Dear Health Care Professional Letter: Clarification of risk factors for severe, life-threatening and fatal hepatotoxicity with VIRAMUNE\u00ae (nevirapine)., 2004. Available at: http:\/\/www.fda.gov\/downloads\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/UCM166534.pdf (accessed April 17, 2013)."},{"key":"10.1016\/j.ijid.2014.08.012_bib0105","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/00126334-200404150-00014","article-title":"Hepatotoxicity associated with nevirapine use","volume":"35","author":"Baylor","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2014.08.012_bib0115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF02599836","article-title":"Predicting cutaneous hypersensitivity reactions to cotrimoxazole in HIV-infected individuals receiving primary Pneumocystis carinii pneumonia prophylaxis","volume":"10","author":"Hennessy","year":"1995","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ijid.2014.08.012_bib0120","doi-asserted-by":"crossref","first-page":"e106141","DOI":"10.1371\/journal.pone.0106141","article-title":"Multicenter study of trimethoprim\/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2014.08.012_bib0125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jac\/dkm243","article-title":"Incidence of abacavir hypersensitivity and its relationship with HLA-B*5701 in HIV-infected patients in Taiwan","volume":"60","author":"Sun","year":"2007","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214016300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214016300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T12:21:18Z","timestamp":1538137278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971214016300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":24,"alternative-id":["S1201971214016300"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2014.08.012","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2014.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}